smoother surface than F2MO4, which would
accommodate the preservation of liposomes in the
matrix.
Yusuf et al. (2017) have created several
formulations with different disaccharides, but the
resultant crystallinity profile was unfavorable
because the phase separations still occurred in the
results. However, this research developed the
formulations using amorphous oligosaccharide. The
finding shows that F2MO3 is the formulation that
meets the desired physical characteristics. The high
HPMC-maltodextrin ratio inhibits molecular re-
arrangement and, thereby, provides better protection
for the liposome vesicles.
4 CONCLUSIONS
The inclusion of Maltodextrin and HPMC as a
dispersion matrix into the liposome formulations
potentially inhibits crystal formation during the
drying process and, consequently, provides better
protection for the lipid bilayer in liposomes.
REFERENCES
Agger, E.M., Rosenkrands, I., Hansen, J., Brahimi, K.,
Vandahl, B.S., Aagaard, C., Werninghaus, K.,
Kirschning, C., Lang, R., Christensen, D., Theisen,
M., Follmann, F., & Andersen, P., 2008. Cationic
Liposomes Formulated with Synthetic Mycobacterial
Cord factor (CAF01): A Versatile Adjuvant for
Vaccines with Different Immunological Requirements.
PLOS ONE 3, e3116.
https://doi.org/10.1371/journal.pone.0003116
Corveleyn, S., & Remon, J.P., 1996. Maltodextrins as
lyoprotectants in the lyophilization of a model protein,
LDH. Pharm. Res. 13, 146–150.
Ingvarsson, P.T., Yang, M., Nielsen, H.M., Rantanen, J.,
& Foged, C., 2011. Stabilization of liposomes during
drying. Expert Opinion on Drug Delivery 8, 375–388.
https://doi.org/10.1517/17425247.2011.553219
Kallerup, R.S., Madsen, C.M., Schiøth, M.L., Franzyk, H.,
Rose, F., Christensen, D., Korsholm, K.S., & Foged,
C., 2015. Influence of trehalose 6,6′-diester (TDX)
chain length on the physicochemical and
immunopotentiating properties of DDA/TDX
liposomes. European Journal of Pharmaceutics and
Biopharmaceutics 90, 80–89.
https://doi.org/10.1016/j.ejpb.2014.10.015
Kaur, R., Henriksen-Lacey, M., Wilkhu, J., Devitt, A.,
Christensen, D., & Perrie, Y., 2014. Effect of
Incorporating Cholesterol into DDA: TDB Liposomal
Adjuvants on Bilayer Properties, Biodistribution, and
Immune Responses. Molecular Pharmaceutics 11,
197–207. https://doi.org/10.1021/mp400372j
Kett, V., Yusuf, H., McCarthy, H., & Chen, K.H., 2015.
Liposomal delivery system. US Patent Document
Li, J., Hu, M., Xu, H., Yu, X., Ye, F., Wang, K., Luan, X.,
Li, L., & Zhang, D., 2016. Influence of type and
proportion of lyoprotectants on lyophilized
ginsenoside Rg3 liposomes: Lyophilized ginsenoside
Rg3 liposomes. Journal of Pharmacy and
Pharmacology 68, 1–13.
https://doi.org/10.1111/jphp.12489
Montanheiro, T.L. do A., Passador, F.R., Oliveira, M.P.
de, Durán, N., Lemes, A.P., Montanheiro, T.L. do A.,
Passador, F.R., Oliveira, M.P. de, Durán, N., &
Lemes, A.P., 2016. Preparation and Characterization
of Maleic Anhydride Grafted Poly (Hydroxybutyrate-
CO-Hydroxyvalerate) – PHBV-g-MA. Materials
Research 19, 229–235. https://doi.org/10.1590/1980-
5373-MR-2015-0496
Nugraheni, R.W., Setyawan, D., & Yusuf, H., 2017.
Physical Characteristics of Liposomal Formulation
Dispersed in HPMC Matrix and Freeze-Dried Using
Maltodextrin and Mannitol as Lyoprotectant.
Pharmaceutical Sciences, 23, 285–292.
https://doi.org/10.15171/PS.2017.42
Pereira, G.C., Rzatki, F.D., Mazzaferro, L., Forin, D.M.,
Barra, G.M. de O., Pereira, G.C., Rzatki, F.D.,
Mazzaferro, L., Forin, D.M., & Barra, G.M. de O.,
2016. Mechanical and Thermo-Physical Properties of
Short Glass Fiber Reinforced Polybutylene
Terephthalate upon Aging in Lubricant/Refrigerant
Mixture. Materials Research 19, 1310–1318.
https://doi.org/10.1590/1980-5373-mr-2016-0339
Yu, L., 2001. Amorphous pharmaceutical solids:
preparation, characterization and stabilization.
Advanced Drug Delivery Reviews 48, 27–42.
https://doi.org/10.1016/S0169-409X(01)00098-9
Yusuf, H., Nugraheni, R., Mulyadi, N.A., Setyawan, D., &
Rosita, N., 2017. Phase behavior of dried–DDA
liposomal formulation dispersed in HPMC matrix in
the presence of saccharides. Int J PharmTech Res 10,
50–56.